New York, NY, United States of America

Jennifer Lue

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Columbia University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Lue. Retrieved from https://idiyas.com/inventor/jennifer-lue

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Jennifer Lue

Introduction

Jennifer Lue is an accomplished inventor based in New York, NY (US). She has made significant contributions to the field of cancer treatment, particularly in the area of lymphoma therapy. Her innovative approach combines different therapeutic agents to enhance treatment efficacy.

Latest Patents

Jennifer Lue holds 1 patent for her work titled "Combination therapy of lymphoma." This patent outlines methods and compositions for treating cancer, specifically targeting lymphoma. The invention involves administering an EZH2 inhibitor alongside an HDAC inhibitor, which together produce a synergistic effect on cancer treatment compared to using either inhibitor alone.

Career Highlights

Jennifer Lue is affiliated with Columbia University, where she conducts her research and develops her innovative therapies. Her work has garnered attention for its potential to improve outcomes for patients suffering from lymphoma.

Collaborations

Jennifer collaborates with notable colleagues, including Jennifer Effie Amengual and Owen Anthony O'Connor. These partnerships enhance her research efforts and contribute to the advancement of cancer treatment methodologies.

Conclusion

Jennifer Lue's innovative work in cancer therapy exemplifies the potential of combining different treatment modalities to improve patient outcomes. Her contributions to the field are paving the way for more effective cancer treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…